Longboard Pharmaceuticals Stock Market Value
| LBPH Stock | USD 59.91 0.11 0.18% |
| Symbol | Longboard |
Longboard Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longboard Pharmaceuticals. If investors know Longboard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longboard Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.25) | Return On Assets (0.31) | Return On Equity (0.47) |
The market value of Longboard Pharmaceuticals is measured differently than its book value, which is the value of Longboard that is recorded on the company's balance sheet. Investors also form their own opinion of Longboard Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Longboard Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longboard Pharmaceuticals' market value can be influenced by many factors that don't directly affect Longboard Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longboard Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Longboard Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longboard Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Longboard Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Longboard Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Longboard Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Longboard Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Longboard Pharmaceuticals or generate 0.0% return on investment in Longboard Pharmaceuticals over 30 days. Longboard Pharmaceuticals is related to or competes with Molecular Partners, MediciNova, Anebulo Pharmaceuticals, Champions Oncology, Werewolf Therapeutics, Edgewise Therapeutics, and Celcuity LLC. Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medici... More
Longboard Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Longboard Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Longboard Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.94 | |||
| Information Ratio | 0.1208 | |||
| Maximum Drawdown | 52.03 | |||
| Value At Risk | (5.74) | |||
| Potential Upside | 11.28 |
Longboard Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Longboard Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Longboard Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Longboard Pharmaceuticals historical prices to predict the future Longboard Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.115 | |||
| Jensen Alpha | 0.8582 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.231 | |||
| Treynor Ratio | 0.724 |
Longboard Pharmaceuticals Backtested Returns
Longboard Pharmaceuticals is somewhat reliable given 3 months investment horizon. Longboard Pharmaceuticals has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.09% are justified by taking the suggested risk. Use Longboard Pharmaceuticals Downside Deviation of 3.94, mean deviation of 3.43, and Risk Adjusted Performance of 0.115 to evaluate company specific risk that cannot be diversified away. Longboard Pharmaceuticals holds a performance score of 11 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.42, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Longboard Pharmaceuticals will likely underperform. Use Longboard Pharmaceuticals treynor ratio, kurtosis, relative strength index, as well as the relationship between the downside variance and day median price , to analyze future returns on Longboard Pharmaceuticals.
Auto-correlation | 0.34 |
Below average predictability
Longboard Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Longboard Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Longboard Pharmaceuticals price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Longboard Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Longboard Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Longboard Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Longboard Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Longboard Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Longboard Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Longboard Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Longboard Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Longboard Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Longboard Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Longboard Pharmaceuticals Lagged Returns
When evaluating Longboard Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Longboard Pharmaceuticals stock have on its future price. Longboard Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Longboard Pharmaceuticals autocorrelation shows the relationship between Longboard Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Longboard Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Longboard Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Longboard Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Longboard Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Longboard Pharmaceuticals Stock:Check out Longboard Pharmaceuticals Correlation, Longboard Pharmaceuticals Volatility and Longboard Pharmaceuticals Alpha and Beta module to complement your research on Longboard Pharmaceuticals. For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Longboard Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.